Mayne Pharma Group Ltd.ASX: MYX

FDA approval and first generic launch of Acticlate tablets

· Issued by Mayne Pharma Group Ltd.

Filed with ASX · · 1 page · English

15 Jun 2017, Adelaide Australia: Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for doxycycline hyclate immediate release (IR) tablets (75 mg and 150 mg) in the United States. Mayne Pharma has immediately commenced commercial launch to customers in the US. Doxycycline hy

Mayne Pharma Group Ltd. on 6ix

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases